Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Publication year range
1.
Blood Adv ; 2(5): 559-564, 2018 03 13.
Article in English | MEDLINE | ID: mdl-29523528

ABSTRACT

Stringent complete remission (sCR) of acute myeloid leukemia is defined as normal hematopoiesis after therapy. Less sCR, including non-sCR, was introduced as insufficient blood platelet, neutrophil, or erythrocyte recovery. These latter characteristics were defined retrospectively as postremission transfusion dependency and were suggested to be of prognostic value. In the present report, we evaluated the prognostic impact of achieving sCR and non-sCR in the Danish National Acute Leukaemia Registry, including 769 patients registered with classical CR (ie, <5% blasts in the postinduction bone marrow analysis). Individual patients were classified as having sCR (n = 360; 46.8%) or non-sCR (n = 409; 53.2%) based on data from our national laboratory and transfusion databases. Survival analysis revealed that patients achieving sCR had superior overall survival (hazard ratio [HR], 1.34; 95% confidence interval [CI], 1.10-1.64) as well as relapse-free survival (HR, 1.25; 95% CI, 1.03-1.51) compared with those with non-sCR after adjusting for covariates. Cox regression analysis regarding the impact of the stringent criteria for blood cell recovery identified these as significant and independent variables. In conclusion, this real-life register study supports the international criteria for response evaluation on prognosis and, most importantly, documents each of the 3 lineage recovery criteria as contributing independently.


Subject(s)
Leukemia, Myeloid, Acute/diagnosis , Adult , Aged , Cell Lineage , Denmark/epidemiology , Humans , Leukemia, Myeloid, Acute/epidemiology , Leukemia, Myeloid, Acute/mortality , Leukemia, Myeloid, Acute/therapy , Middle Aged , Prognosis , Registries , Remission Induction/methods , Survival Analysis
2.
J Med Case Rep ; 11(1): 150, 2017 Jun 07.
Article in English | MEDLINE | ID: mdl-28592301

ABSTRACT

BACKGROUND: Bacterial meningitis commonly presents with symptoms such as headache, impaired consciousness, neck stiffness, and fever. In most cases, cerebrospinal fluid analysis will yield white cell counts >100/mm3. Atypical presentations occur, especially in the very young or very elderly and the immunocompromised. We report an unusual case of pneumococcal meningitis in a healthy 78-year-old Danish woman who presented with clinical features mimicking a stroke with normal cerebrospinal fluid parameters and without microscopic evidence of bacteria. CASE PRESENTATION: The patient was admitted after being found unconscious on her bed. Upon admittance, she was considered confused, with a temperature of 39.4 °C and slight neutrophilic leukocytosis, but no neck stiffness. A neurological examination revealed bilateral horizontal nystagmus, unstable eye movements, and suspected right-sided gaze paralysis. Cerebrospinal fluid analysis revealed normal parameters, and the microscopy result was negative for bacteria. The most likely diagnosis was considered to be stroke with concomitant infection. However, cerebrospinal fluid and blood cultures subsequently were rapidly positive for pneumococci. Neither immunodeficiency nor blood contamination was considered a likely cause of this discrepancy. CONCLUSIONS: This case emphasizes the need to consider a multidisciplinary approach and empirical meningitis treatment until diagnostic results from microbiological cultures are obtained.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Ceftriaxone/therapeutic use , Consciousness Disorders/microbiology , Dexamethasone/therapeutic use , Meningitis, Pneumococcal/microbiology , Penicillin G/therapeutic use , Stroke/diagnosis , Aged , Consciousness Disorders/cerebrospinal fluid , Consciousness Disorders/physiopathology , Diagnosis, Differential , Female , Humans , Meningitis, Pneumococcal/cerebrospinal fluid , Meningitis, Pneumococcal/drug therapy , Meningitis, Pneumococcal/physiopathology , Treatment Outcome
3.
Medicine (Baltimore) ; 96(18): e6686, 2017 May.
Article in English | MEDLINE | ID: mdl-28471963

ABSTRACT

Cerebrospinal fluid (CSF) analysis is the most important tool for assessing central nervous system (CNS) disease. An elevated CSF leukocyte count rarely provides the final diagnosis, but is almost always an indicator of inflammation within the CNS.The present study investigated the variety of diseases associated with CSF pleocytosis.CSF analyses were identified through the biochemical database used in the capital region of Denmark in the period from 2003 to 2010. In patients >15 years, clinical diagnoses associated with the finding of a CSF leukocyte count >10 × 10 cells/L were obtained from discharge records and patient files.A total of 1058 CSF samples from 1054 patients were included in the analysis. The median age was 50 (interquartile range: 36-67) and 53% were male. Eighty-one different diagnoses were identified in 1058 cases with an elevated CSF leukocyte count, besides unknown causes. Infections were the most common cause of CSF pleocytosis (61.4%) followed by miscellaneous causes (12.7%), vascular (9.7%), neurodegenerative (7%), neoplastic (5%), and inflammatory conditions (4.2%). Only infections presented with leukocyte counts >10,000 × 10/L. Infections represented 82.6% of all cases with a leukocyte count >100 × 10/L whereas 56.3% of cases with at leukocyte counts <100 × 10/L were dominated by disease not related to infection.The present study may serve as a reminder to clinicians of what diseases and disease categories to suspect when patients present with CSF biochemistry indicating CNS inflammation.


Subject(s)
Central Nervous System Diseases/cerebrospinal fluid , Leukocytosis/cerebrospinal fluid , Adult , Aged , Area Under Curve , Central Nervous System Diseases/etiology , Denmark , Diagnosis, Differential , Female , Humans , Leukocyte Count , Leukocytosis/etiology , Male , Middle Aged , ROC Curve , Retrospective Studies
4.
Dan Med J ; 63(12)2016 Dec.
Article in English | MEDLINE | ID: mdl-27910796

ABSTRACT

INTRODUCTION: The medical decision capacity of emergency departments (ED) may rest within the department itself or depend on external consultation. The stepwise development of the ED at Zealand University Hospital, Køge, was used to analyse the influence of medical organisation in the ED on the hospital admission pattern. METHODS: Data were recorded for the month of September of 2009, 2012 and 2014. These periods corresponded to the establishment of the department in 2009 and the 2012-period before organisational change was initiated in 2013, with a substantial increase in the number of senior physicians directly in charge of clinical decisions and the establishment of a limited bedding capacity. In 2014, the changes had been fully implemented. We analysed the number of patients admitted and their length of stay (LOS) in the ED and in the Department of Internal Medicine (DoM). The 30-day readmission and mortality rates were used as quality indicators. RESULTS: A total of 1,106, 1,354 and 1,470 patients were admitted to the ED in 2009, 2012 and 2014, respectively. In 2009 and 2012, 42% of the patients were admitted to the DoM. In 2014, only 22% were admitted. The mean LOS for long-term admission at the DoM increased by 1.4 days from 2009 to 2014. Readmission and mortality rates did not change in three periods analysed. CONCLUSION: Independent medical decision capacity and bed resources in the ED effectively change hospital logistics and reduce the number of admissions without negatively affecting patient safety in terms of readmission or short-term mortality. FUNDING: none. TRIAL REGISTRATION: not relevant.


Subject(s)
Emergency Service, Hospital/organization & administration , Hospitalization/trends , Internal Medicine/statistics & numerical data , Mortality/trends , Patient Admission/statistics & numerical data , Quality of Health Care , Age Factors , Aged , Clinical Decision-Making , Denmark , Female , Humans , Length of Stay/trends , Male , Middle Aged , Patient Admission/trends , Patient Readmission/trends
5.
J Infect Dis ; 214(8): 1198-204, 2016 10 15.
Article in English | MEDLINE | ID: mdl-27354366

ABSTRACT

BACKGROUND: CD163, a monocyte- and macrophage-specific scavenger receptor, is shed as soluble CD163 (sCD163) during the proinflammatory response. Here, we assessed the association between plasma sCD163 levels and progression to AIDS and all-cause mortality among individuals infected with human immunodeficiency virus type 1 (HIV). METHODS: Plasma sCD163 levels were measured in 933 HIV-infected individuals. Hazard ratios (HRs) with 95% confidence intervals (CIs) associated with mortality were computed by Cox proportional hazards regression. RESULTS: At baseline, 86% were receiving antiretroviral treatment, 73% had plasma a HIV RNA level of <50 copies/mL, and the median CD4(+) T-cell count was 503 cells/µL. During 10.5 years of follow-up, 167 (17.9%) died. Plasma sCD163 levels were higher in nonsurvivors than in survivors (4.92 mg/L [interquartile range {IQR}, 3.29-8.65 mg/L] vs 3.16 mg/L [IQR, 2.16-4.64 mg/L]; P = .0001). The cumulative incidence of death increased with increasing plasma sCD163 levels, corresponding to a 6% or 35% increased risk of death for each milligram per liter or quartile increase, respectively, in baseline plasma sCD163 level (adjusted HR, 1.06 [95% CI, 1.03-1.09] and 1.35 [95% CI, 1.13-1.63], respectively). CONCLUSIONS: Plasma sCD163 was an independent marker of all-cause mortality in a cohort of HIV-infected individuals, suggesting that monocyte/macrophage activation may play a role in HIV pathogenesis and be a target of intervention.


Subject(s)
Antigens, CD/blood , Antigens, Differentiation, Myelomonocytic/blood , HIV Infections/blood , HIV Infections/mortality , Plasma/metabolism , Receptors, Cell Surface/blood , Adult , Anti-Retroviral Agents/therapeutic use , Biomarkers/blood , Disease Progression , Female , HIV Infections/drug therapy , HIV-1/drug effects , Humans , Macrophage Activation/physiology , Macrophages/metabolism , Male , Middle Aged , Monocytes/metabolism , Proportional Hazards Models , Receptors, Cell Surface/metabolism
6.
Ugeskr Laeger ; 174(22): 1521-4, 2012 May 28.
Article in Danish | MEDLINE | ID: mdl-22668646

ABSTRACT

The global shortage of health workers in a world with interdependence and vast inequalities in health calls for internationally coordinated context-sensitive actions to build a global health workforce of sufficient quantity and quality. This status article describes the global crisis in the health workforce and some solutions and stakeholders in play.


Subject(s)
Global Health , Health Workforce , Africa South of the Sahara/epidemiology , Delivery of Health Care , Developing Countries , Emigration and Immigration , Global Health/ethics , Health Personnel/education , Health Personnel/statistics & numerical data , Health Workforce/ethics , Health Workforce/statistics & numerical data , Humans
SELECTION OF CITATIONS
SEARCH DETAIL
...